2 insiders bought €893k of shares over the last 90 days, the latest by Klara Eiritz, filed 17 Sept 2026.
+9 other insiders
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analysts rate Elekta AB (publ) Hold (neutral), based on 15 analysts. Average price target: SEK 57.71.
Transparent value + quality ranking, distinct from the insider signal.
FY ended April 2026 · cache
25 of 108 declarations
Elekta AB (publ), a Swedish health care company listed in Stockholm with a market capitalisation of SEK 21.38 billion, has many purchases but its few sales weigh more: 9 sales worth EUR 23,492,241, median EUR 2,848,048, against 91 purchases worth EUR 12,147,651, median EUR 27,825, or 91% purchases among open-market trades.
Laurent Leksell, Styrelseordförande, is behind the largest lines: a sale of EUR 5,049,240 on September 20, 2023, another of EUR 4,834,585 on October 12, 2021, and a purchase of EUR 7,487,660 on March 22, 2017, where the label is Styrelseledamot/suppleant. AB Bonit Invest, listed as Verkställande direktör (VD), appears with a sale of the same amount as Laurent Leksell's, EUR 4,834,585, on the same day. Jacob Just-Bomholt, VD, bought EUR 876,041 on September 11, 2026. Between August 25, 2022 and September 16, 2022, 10 insiders bought for EUR 503,175.
The 103 filings, from 33 filers, were published between March 7, 2017 and September 24, 2026. The year 2022 has 42, 2018 only one. Carlos Castilleja filed 9 times, all purchases. Insiders hold 2.2% of the capital. Over twelve months: 11 filings, 8 purchases, 2 sales. For 89 purchases the 90-day median is minus 2.4%, with 44% positive (stored past results, not a forecast).
Purchases our model currently ranks for the recommendations list.
All recommendationsHeadquarters: Stockholm, Sweden · Founded: 1972 · Wikipedia article
Source: Wikidata (CC0).